BridgeBio Pharma Inc (BBIO)
27.86
-1.14
(-3.93%)
USD |
NASDAQ |
Jun 14, 16:00
27.89
+0.03
(+0.11%)
After-Hours: 20:00
BridgeBio Pharma Stock Buybacks (Quarterly): -312.32M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -312.32M |
| December 31, 2023 | 3.009M |
| September 30, 2023 | -303.60M |
| June 30, 2023 | 0.17M |
| March 31, 2023 | -142.50M |
| December 31, 2022 | -4.363M |
| September 30, 2022 | 0.596M |
| June 30, 2022 | 0.366M |
| March 31, 2022 | 0.11M |
| December 31, 2021 | 2.253M |
| September 30, 2021 | 143.88M |
| June 30, 2021 | 7.589M |
| Date | Value |
|---|---|
| March 31, 2021 | 51.02M |
| December 31, 2020 | 0.471M |
| September 30, 2020 | 0.243M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 75.00M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -366.24M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 36.30M |
| September 30, 2018 | -35.11M |
| June 30, 2018 | -96.72M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-366.24M
Minimum
Sep 2019
143.88M
Maximum
Sep 2021
-42.22M
Average
0.2065M
Median
Stock Buybacks (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -- |
| Pfizer Inc | -- |
| Arcellx Inc | 0.00 |
| Biomarin Pharmaceutical Inc | -- |
| Viking Therapeutics Inc | -597.12M |